PD-1 VEGF Bispecific Antibody

North Chicago, Illinois, USA, August 21, 2026 AbbVie has announced new clinical, translational and real-world research findings that will...

Hong Kong, July 27, 2026 Akeso, Inc. has announced that the first patient has been dosed in the Phase...